The prevalence of symptoms in participants with PD within each neuroanatomical domain for LRRK2 p.G2019S, GBA1 p.N409S, and noncarriers is shown in Figure 3 (dual carrier results reported in Figure S5). This evidence concerns the gene GBA1 and Parkinson disease.